Aurora SK - Search Results

1

Safety and efficacy of galcanezumab in patients for whom previous migraine preventive medication from two to four categories had failed (CONQUER): a multicentre, randomised, double-blind, placebo-controlled, phase 3b trial.

Mulleners WM, Kim BK, Láinez MJA, Lanteri-Minet M, Pozo-Rosich P, Wang S, Tockhorn-Heidenreich A, Aurora SK, Nichols RM, Yunes-Medina L, Detke HC. Mulleners WM, et al. Among authors: aurora sk. Lancet Neurol. 2020 Oct;19(10):814-825. doi: 10.1016/S1474-4422(20)30279-9. Epub 2020 Sep 16. Lancet Neurol. 2020. PMID: 32949542 Clinical Trial.

2

Migraine's magnetic attraction.

Aurora SK, Chronicle EP. Aurora SK, et al. Lancet Neurol. 2002 Aug;1(4):211. doi: 10.1016/s1474-4422(02)00097-2. Lancet Neurol. 2002. PMID: 12849451 No abstract available.

3

Cortical inhibition is reduced in chronic and episodic migraine and demonstrates a spectrum of illness.

Aurora SK, Barrodale P, Chronicle EP, Mulleners WM. Aurora SK, et al. Headache. 2005 May;45(5):546-52. doi: 10.1111/j.1526-4610.2005.05108.x. Headache. 2005. PMID: 15953273

4

Botulinum toxin type a prophylactic treatment of episodic migraine: a randomized, double-blind, placebo-controlled exploratory study.

Aurora SK, Gawel M, Brandes JL, Pokta S, Vandenburgh AM; BOTOX North American Episodic Migraine Study Group. Aurora SK, et al. Headache. 2007 Apr;47(4):486-99. doi: 10.1111/j.1526-4610.2006.00624.x. Headache. 2007. PMID: 17445098 Clinical Trial.

5

Revisiting the efficacy of sumatriptan therapy during the aura phase of migraine.

Aurora SK, Barrodale PM, McDonald SA, Jakubowski M, Burstein R. Aurora SK, et al. Headache. 2009 Jul;49(7):1001-4. doi: 10.1111/j.1526-4610.2009.01429.x. Epub 2009 Apr 28. Headache. 2009. PMID: 19438735 Free PMC article. Clinical Trial.

6

A randomized, double blind, placebo-controlled study of MAP0004 in adult patients with migraine.

Aurora SK, Rozen TD, Kori SH, Shrewsbury SB. Aurora SK, et al. Headache. 2009 Jun;49(6):826-37. doi: 10.1111/j.1526-4610.2009.01453.x. Headache. 2009. PMID: 19545249 Clinical Trial.

7

Single-pulse transcranial magnetic stimulation for acute treatment of migraine with aura: a randomised, double-blind, parallel-group, sham-controlled trial.

Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Pearlman SH, Fischell RE, Ruppel PL, Goadsby PJ. Lipton RB, et al. Among authors: aurora sk. Lancet Neurol. 2010 Apr;9(4):373-80. doi: 10.1016/S1474-4422(10)70054-5. Epub 2010 Mar 4. Lancet Neurol. 2010. PMID: 20206581 Clinical Trial.

8

Pathophysiology of migraine.

Aurora SK, Nagesh V. Aurora SK, et al. Handb Clin Neurol. 2010;97:267-73. doi: 10.1016/S0072-9752(10)97022-X. Handb Clin Neurol. 2010. PMID: 20816428 No abstract available.

9

MAP0004, orally inhaled DHE: a randomized, controlled study in the acute treatment of migraine.

Aurora SK, Silberstein SD, Kori SH, Tepper SJ, Borland SW, Wang M, Dodick DW. Aurora SK, et al. Headache. 2011 Apr;51(4):507-17. doi: 10.1111/j.1526-4610.2011.01869.x. Headache. 2011. PMID: 21457235 Clinical Trial.

10

Migraine headache is present in the aura phase: a prospective study.

Hansen JM, Lipton RB, Dodick DW, Silberstein SD, Saper JR, Aurora SK, Goadsby PJ, Charles A. Hansen JM, et al. Among authors: aurora sk. Neurology. 2012 Nov 13;79(20):2044-9. doi: 10.1212/WNL.0b013e3182749eed. Epub 2012 Oct 31. Neurology. 2012. PMID: 23115208 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

139 results

Search Page